Appraisal of International Guidelines for Cutaneous Melanoma Management using the AGREE II assessment tool
Background: The evidence base behind new melanoma treatments is rapidly accumulating. This is not necessarily reflected in current guidance. A recent UK-based expert consensus statement, published in JPRAS, has called for updates to the widely accepted 2015 National Institute for Health and Care Exc...
Main Authors: | C. Jacklin, M. Tan, S. Sravanam, C.J. Harrison |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | JPRAS Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352587821001017 |
Similar Items
-
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
by: Theresa Steeb, et al.
Published: (2020-06-01) -
A Review of Contemporary Guidelines and Evidence for Wide Local Excision in Primary Cutaneous Melanoma Management
by: Sophie E. Orme, et al.
Published: (2024-02-01) -
Association between excision margins and local recurrence in 1407 patients with primary in situ melanomasCapsule Summary
by: Licata Gaetano, MD, et al.
Published: (2022-09-01) -
Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use
by: Wiebke Hoffmann-Eßer, et al.
Published: (2018-02-01) -
Development and validation of two online dynamic nomograms for patients with non‐distant metastatic cutaneous melanoma based on surgical approaches
by: Shiqi Wang, et al.
Published: (2023-09-01)